封面
市场调查报告书
商品编码
1433636

临床化学分析仪市场规模、份额和趋势分析报告:2024-2030 年按产品、测试、最终用途、地区和细分市场进行的预测

Clinical Chemistry Analyzers Market Size, Share & Trends Analysis Report By Product (Analyzers, Reagents), By Test (Basic Metabolic Panel, Electrolyte Panel), By End-use, By Region, And Segment Forecasts, 2024 - 2030

出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格

临床化学分析仪市场成长与趋势:

Grand View Research, Inc.最新报告显示,预计2024年至2030年全球临床生化分析仪市场规模将以4.7%的复合年增长率成长,2030年达到258.8亿美元。

慢性病的增加迫切需要实施临床化学分析仪,从而在预测期内提供更大的成长空间。此外,更容易患慢性病的老年人和肥胖人口的增加预计将推高需求。因此,需要高容量分析设备的样品量不断增加,从而推动了市场的成长。

此外,人们对临床化学分析仪优势的认识不断提高也是市场驱动因素。先进化学分析仪的出现正在提高照护现场检测能力并增加市场的潜在成长机会。此外,分析前、分析和分析后阶段的分析设备和试剂的技术进步提高了诊断能力和整体效率。这些进步包括微晶片、感测器、化学计量学和机器人技术的出现。此外,公共和私人医疗机构不断努力提高资料可靠性,导致自动化化学分析仪和免疫检测系统的快速集成,从而导致实验室工作量整体减少,需求增加。

临床化学分析仪市场亮点

  • 以产品来看,试剂细分市场在 2023 年以 57.4% 的最大销售份额引领市场。这一巨大份额预计是由于市场上存在多种试剂以满足临床医生的不同需求。
  • 按测试类型划分,基础代谢组(BMP)细分市场在2023年占据最大的销售份额,为29.56%。
  • 按最终用途划分,医院业以 2023 年收益占有率最高的 58.32% 领先市场。
  • 由于美国等国家医疗保健支出不断增加,北美地区在 2023 年占据市场收益占有率为 35.6%。
  • 由于目标人口庞大以及印度和中国等国家领先临床化学製造商的渗透率不断提高,预计亚太地区在预测期内将以最快的复合年增长率成长。

目录

第一章调查方法和范围

第 2 章执行摘要

第三章临床生化分析仪市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 临床化学分析仪市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析
    • 价格分析

第四章临床生化分析仪市场:产品评估与趋势分析

  • 2023年及2030年产品市场占有率
  • 细分仪表板
  • 按产品分類的全球临床生化分析仪市场展望
  • 2018年至2030年市场规模、预测与趋势分析

第五章临床生化分析仪市场:测试估计和趋势分析

  • 2023 年和 2030 年市场占有率测试
  • 细分仪表板
  • 透过测试全球临床生化分析仪市场前景
  • 2018年至2030年市场规模、预测与趋势分析

第六章临床化学分析仪市场:最终用途估计与趋势分析

  • 2023 年及 2030 年最终用途市场占有率
  • 细分仪表板
  • 按最终用途分類的全球临床化学分析仪市场展望
  • 2018年至2030年市场规模、预测与趋势分析

第七章临床生化分析仪市场:区域估计与趋势分析

  • 2024 年及 2030 年区域市场占有率分析
  • 区域市场仪表板
  • 全球区域市场概述
  • 2018-2030年市场规模趋势分析及预测
  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麦
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东/非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章 竞争形势

  • 主要市场参与企业的最新趋势和影响分析
  • 公司/竞争对手分类
  • 供应商形势
    • Mindray Medical International Limited
    • Thermo Fisher Scientific, Inc.
    • Danaher Corporation(Beckman Coulter)
    • Abbott Laboratories
    • Siemens Healthineers
    • F. Hoffmann-La Roche
    • Horiba, Ltd.
    • Elitech Group
    • Ortho Clinical Diagnostics
    • Randox Laboratories
Product Code: GVR-1-68038-409-3

Clinical Chemistry Analyzers Market Growth & Trends:

The global clinical chemistry analyzers market size is expected to reach USD 25.88 billion by 2030, expanding at a CAGR of 4.7% from 2024 to 2030, according to a new report by Grand View Research, Inc. The growing prevalence of chronic diseases is anticipated to be responsible for the high urgency to adopt clinical chemistry analyzers, which thereby widens the scope for growth during the forecast period. In addition, growing base of geriatric and bariatric population, which is highly susceptible to chronic diseases, is presumed to impel the demand further. Consequently, the resultant high sample volume requiring high capability analyzing devices is driving the market growth.

Moreover, increasing awareness pertaining to benefits associated with these devices is also a high impact rendering driver for clinical chemistry analyzers market. Advent of advanced chemistry analyzers has resulted in improved point-of-care testing capabilities, and thus created high potential growth opportunities for the market. In addition, technological advancements in preanalytical, analytical, and post analytical stages due to analyzing devices & reagents improved their diagnostic capabilities and overall efficiency, which is predicted to propel the growth further. These advancements include advent of microchips, sensors, chemometrics, and robotics. Furthermore, consistent efforts by public as well private healthcare organizations to increase the reliability of data have rapidly engendered the integration of automated chemistry analyzers and immunoassay systems, thereby resulting in overall reduction of workload in laboratories, thus propelling the demand.

Clinical Chemistry Analyzers Market Report Highlights:

  • Based on product, the reagents segment led the market with the largest revenue share of 57.4% in 2023. The substantial share is predicted to be a consequence of a wide array of reagents present in the market, catering to different requirements of clinicians.
  • Based on the test type, the basic metabolic panel (BMP) segment held a market with the largest revenue share of 29.56% in 2023, owing to growing prevalence of lifestyle-induced diseases, such as obesity and other metabolic abnormalities.
  • Based on end-use, the hospitals segment led the market in 2023 with the largest revenue share of 58.32%, owing to the high patient volume, frequent readmissions, and large sample volumes.
  • North America dominated the market with the revenue share of 35.6% in 2023, due to rising healthcare spending in country, such as the U.S.
  • Asia Pacific region is anticipated to grow at the fastest CAGR during the forecast period owing to the presence of a large target population and increasing penetration of leading clinical chemistry product manufacturers in countries, such as India and China.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Test
    • 1.2.3. End Use
    • 1.2.4. Regional scope
    • 1.2.5. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Test Outlook
    • 2.2.3. End Use outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Clinical Chemistry Analyzers Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increase in laboratory automation
      • 3.2.1.2. Increasing prevalence of chronic diseases
      • 3.2.1.3. Increase in technological advancements
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Requirement of high capital investments
      • 3.2.2.2. Stringent regulatory scenario
  • 3.3. Clinical Chemistry Analyzers Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape
    • 3.3.3. Pricing Analysis

Chapter 4. Clinical Chemistry Analyzers Market: Product Estimates & Trend Analysis

  • 4.1. Product Market Share, 2023 & 2030
  • 4.2. Segment Dashboard
  • 4.3. Global Clinical Chemistry Analyzers Market by Product Outlook
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 4.4.1. Analyzers
      • 4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.1.2. Small
      • 4.4.1.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.1.3. Medium
      • 4.4.1.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.1.4. Large
      • 4.4.1.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.1.5. Very Large
      • 4.4.1.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.2. Reagents
      • 4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.2.2. Calibrators
      • 4.4.2.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.2.3. Controls
      • 4.4.2.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.2.4. Standards
      • 4.4.2.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.2.5. Others
      • 4.4.2.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.3. Others
      • 4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Clinical Chemistry Analyzers Market: Test Estimates & Trend Analysis

  • 5.1. Test Market Share, 2023 & 2030
  • 5.2. Segment Dashboard
  • 5.3. Global Clinical Chemistry Analyzers Market by Test Outlook
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 5.4.1. Basic Metabolic Panel
      • 5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.2. Electrolyte Panel
      • 5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.3. Liver Panel
      • 5.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.4. Lipid Profile
      • 5.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.5. Renal Profile
      • 5.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.6. Thyroid Function Panel
      • 5.4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.7. Specialty Chemical Tests
      • 5.4.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Clinical Chemistry Analyzers Market: End Use Estimates & Trend Analysis

  • 6.1. End Use Market Share, 2023 & 2030
  • 6.2. Segment Dashboard
  • 6.3. Global Clinical Chemistry Analyzers Market by End Use Outlook
  • 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 6.4.1. Hospitals
      • 6.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.2. Academic Research Centers
      • 6.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.3. Diagnostic Laboratories
      • 6.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.4. Others
      • 6.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Clinical Chemistry Analyzers Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2024 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Global Regional Market Snapshot
  • 7.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 7.5. North America
    • 7.5.1. U.S.
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Regulatory framework
      • 7.5.1.3. Competitive scenario
      • 7.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.2. Canada
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6. Europe
    • 7.6.1. UK
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Regulatory framework
      • 7.6.1.3. Competitive scenario
      • 7.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.2. Germany
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.3. France
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Regulatory framework
      • 7.6.3.3. Competitive scenario
      • 7.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.4. Italy
      • 7.6.4.1. Key country dynamics
      • 7.6.4.2. Regulatory framework
      • 7.6.4.3. Competitive scenario
      • 7.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.5. Spain
      • 7.6.5.1. Key country dynamics
      • 7.6.5.2. Regulatory framework
      • 7.6.5.3. Competitive scenario
      • 7.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.6. Norway
      • 7.6.6.1. Key country dynamics
      • 7.6.6.2. Regulatory framework
      • 7.6.6.3. Competitive scenario
      • 7.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.7. Sweden
      • 7.6.7.1. Key country dynamics
      • 7.6.7.2. Regulatory framework
      • 7.6.7.3. Competitive scenario
      • 7.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.8. Denmark
      • 7.6.8.1. Key country dynamics
      • 7.6.8.2. Regulatory framework
      • 7.6.8.3. Competitive scenario
      • 7.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7. Asia Pacific
    • 7.7.1. Japan
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Regulatory framework
      • 7.7.1.3. Competitive scenario
      • 7.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.2. China
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.3. India
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Regulatory framework
      • 7.7.3.3. Competitive scenario
      • 7.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.4. Australia
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Regulatory framework
      • 7.7.4.3. Competitive scenario
      • 7.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.5. South Korea
      • 7.7.5.1. Key country dynamics
      • 7.7.5.2. Regulatory framework
      • 7.7.5.3. Competitive scenario
      • 7.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.6. Thailand
      • 7.7.6.1. Key country dynamics
      • 7.7.6.2. Regulatory framework
      • 7.7.6.3. Competitive scenario
      • 7.7.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.8. Latin America
    • 7.8.1. Brazil
      • 7.8.1.1. Key country dynamics
      • 7.8.1.2. Regulatory framework
      • 7.8.1.3. Competitive scenario
      • 7.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.8.2. Mexico
      • 7.8.2.1. Key country dynamics
      • 7.8.2.2. Regulatory framework
      • 7.8.2.3. Competitive scenario
      • 7.8.2.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.8.3. Argentina
      • 7.8.3.1. Key country dynamics
      • 7.8.3.2. Regulatory framework
      • 7.8.3.3. Competitive scenario
      • 7.8.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.9. MEA
    • 7.9.1. South Africa
      • 7.9.1.1. Key country dynamics
      • 7.9.1.2. Regulatory framework
      • 7.9.1.3. Competitive scenario
      • 7.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.9.2. Saudi Arabia
      • 7.9.2.1. Key country dynamics
      • 7.9.2.2. Regulatory framework
      • 7.9.2.3. Competitive scenario
      • 7.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.9.3. UAE
      • 7.9.3.1. Key country dynamics
      • 7.9.3.2. Regulatory framework
      • 7.9.3.3. Competitive scenario
      • 7.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.9.4. Kuwait
      • 7.9.4.1. Key country dynamics
      • 7.9.4.2. Regulatory framework
      • 7.9.4.3. Competitive scenario
      • 7.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
  • 8.3. Vendor Landscape
    • 8.3.1. List of key distributors and channel partners
    • 8.3.2. Key customers
    • 8.3.3. Key company market share analysis, 2023
    • 8.3.4. Mindray Medical International Limited
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Product benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. Thermo Fisher Scientific, Inc.
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Product benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. Danaher Corporation (Beckman Coulter)
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Product benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. Abbott Laboratories
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Product benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. Siemens Healthineers
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Product benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. F. Hoffmann-La Roche
      • 8.3.9.1. Company overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. Product benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. Horiba, Ltd.
      • 8.3.10.1. Company overview
      • 8.3.10.2. Financial performance
      • 8.3.10.3. Product benchmarking
      • 8.3.10.4. Strategic initiatives
    • 8.3.11. Elitech Group
      • 8.3.11.1. Company overview
      • 8.3.11.2. Financial performance
      • 8.3.11.3. Product benchmarking
      • 8.3.11.4. Strategic initiatives
    • 8.3.12. Ortho Clinical Diagnostics
      • 8.3.12.1. Company overview
      • 8.3.12.2. Financial performance
      • 8.3.12.3. Product benchmarking
      • 8.3.12.4. Strategic initiatives
    • 8.3.13. Randox Laboratories
      • 8.3.13.1. Company overview
      • 8.3.13.2. Financial performance
      • 8.3.13.3. Product benchmarking
      • 8.3.13.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America clinical chemistry analyzers market, by region, 2018 - 2030 (USD Million)
  • Table 3 North America clinical chemistry analyzers market, by product, 2018 - 2030 (USD Million)
  • Table 4 North America clinical chemistry analyzers market, by test, 2018 - 2030 (USD Million)
  • Table 5 North America clinical chemistry analyzers market, by end use, 2018 - 2030 (USD Million)
  • Table 6 U.S. clinical chemistry analyzers market, by product, 2018 - 2030 (USD Million)
  • Table 7 U.S. clinical chemistry analyzers market, by test, 2018 - 2030 (USD Million)
  • Table 8 U.S. clinical chemistry analyzers market, by end use, 2018 - 2030 (USD Million)
  • Table 9 Canada clinical chemistry analyzers market, by product, 2018 - 2030 (USD Million)
  • Table 10 Canada clinical chemistry analyzers market, by test, 2018 - 2030 (USD Million)
  • Table 11 Canada clinical chemistry analyzers market, by end use, 2018 - 2030 (USD Million)
  • Table 12 Europe clinical chemistry analyzers market, by region, 2018 - 2030 (USD Million)
  • Table 13 Europe clinical chemistry analyzers market, by product, 2018 - 2030 (USD Million)
  • Table 14 Europe clinical chemistry analyzers market, by test, 2018 - 2030 (USD Million)
  • Table 15 Europe clinical chemistry analyzers market, by end use, 2018 - 2030 (USD Million)
  • Table 16 Germany clinical chemistry analyzers market, by product, 2018 - 2030 (USD Million)
  • Table 17 Germany clinical chemistry analyzers market, by test, 2018 - 2030 (USD Million)
  • Table 18 Germany clinical chemistry analyzers market, by end use, 2018 - 2030 (USD Million)
  • Table 19 UK clinical chemistry analyzers market, by product, 2018 - 2030 (USD Million)
  • Table 20 UK clinical chemistry analyzers market, by test, 2018 - 2030 (USD Million)
  • Table 21 UK clinical chemistry analyzers market, by end use, 2018 - 2030 (USD Million)
  • Table 22 France clinical chemistry analyzers market, by product, 2018 - 2030 (USD Million)
  • Table 23 France clinical chemistry analyzers market, by test, 2018 - 2030 (USD Million)
  • Table 24 France clinical chemistry analyzers market, by end use, 2018 - 2030 (USD Million)
  • Table 25 Italy clinical chemistry analyzers market, by product, 2018 - 2030 (USD Million)
  • Table 26 Italy clinical chemistry analyzers market, by test, 2018 - 2030 (USD Million)
  • Table 27 Italy clinical chemistry analyzers market, by end use, 2018 - 2030 (USD Million)
  • Table 28 Spain clinical chemistry analyzers market, by product, 2018 - 2030 (USD Million)
  • Table 29 Spain clinical chemistry analyzers market, by test, 2018 - 2030 (USD Million)
  • Table 30 Spain clinical chemistry analyzers market, by end use, 2018 - 2030 (USD Million)
  • Table 31 Denmark clinical chemistry analyzers market, by product, 2018 - 2030 (USD Million)
  • Table 32 Denmark clinical chemistry analyzers market, by test, 2018 - 2030 (USD Million)
  • Table 33 Denmark clinical chemistry analyzers market, by end use, 2018 - 2030 (USD Million)
  • Table 34 Sweden clinical chemistry analyzers market, by product, 2018 - 2030 (USD Million)
  • Table 35 Sweden clinical chemistry analyzers market, by test, 2018 - 2030 (USD Million)
  • Table 36 Sweden clinical chemistry analyzers market, by end use, 2018 - 2030 (USD Million)
  • Table 37 Norway clinical chemistry analyzers market, by product, 2018 - 2030 (USD Million)
  • Table 38 Norway clinical chemistry analyzers market, by test, 2018 - 2030 (USD Million)
  • Table 39 Norway clinical chemistry analyzers market, by end use, 2018 - 2030 (USD Million)
  • Table 40 Asia Pacific clinical chemistry analyzers market, by region, 2018 - 2030 (USD Million)
  • Table 41 Asia Pacific clinical chemistry analyzers market, by product, 2018 - 2030 (USD Million)
  • Table 42 Asia Pacific clinical chemistry analyzers market, by test, 2018 - 2030 (USD Million)
  • Table 43 Asia Pacific clinical chemistry analyzers market, by end use, 2018 - 2030 (USD Million)
  • Table 44 China clinical chemistry analyzers market, by product, 2018 - 2030 (USD Million)
  • Table 45 China clinical chemistry analyzers market, by test, 2018 - 2030 (USD Million)
  • Table 46 China clinical chemistry analyzers market, by end use, 2018 - 2030 (USD Million)
  • Table 47 Japan clinical chemistry analyzers market, by product, 2018 - 2030 (USD Million)
  • Table 48 Japan clinical chemistry analyzers market, by test, 2018 - 2030 (USD Million)
  • Table 49 Japan clinical chemistry analyzers market, by end use, 2018 - 2030 (USD Million)
  • Table 50 India clinical chemistry analyzers market, by product, 2018 - 2030 (USD Million)
  • Table 51 India clinical chemistry analyzers market, by test, 2018 - 2030 (USD Million)
  • Table 52 India clinical chemistry analyzers market, by end use, 2018 - 2030 (USD Million)
  • Table 53 South Korea clinical chemistry analyzers market, by product, 2018 - 2030 (USD Million)
  • Table 54 South Korea clinical chemistry analyzers market, by test, 2018 - 2030 (USD Million)
  • Table 55 South Korea clinical chemistry analyzers market, by end use, 2018 - 2030 (USD Million)
  • Table 56 Australia clinical chemistry analyzers market, by product, 2018 - 2030 (USD Million)
  • Table 57 Australia clinical chemistry analyzers market, by test, 2018 - 2030 (USD Million)
  • Table 58 Australia clinical chemistry analyzers market, by end use, 2018 - 2030 (USD Million)
  • Table 59 Thailand clinical chemistry analyzers market, by product, 2018 - 2030 (USD Million)
  • Table 60 Thailand clinical chemistry analyzers market, by test, 2018 - 2030 (USD Million)
  • Table 61 Thailand clinical chemistry analyzers market, by end use, 2018 - 2030 (USD Million)
  • Table 62 Latin America clinical chemistry analyzers market, by product, 2018 - 2030 (USD Million)
  • Table 63 Latin America clinical chemistry analyzers market, by test, 2018 - 2030 (USD Million)
  • Table 64 Latin America clinical chemistry analyzers market, by end use, 2018 - 2030 (USD Million)
  • Table 65 Brazil clinical chemistry analyzers market, by product, 2018 - 2030 (USD Million)
  • Table 66 Brazil clinical chemistry analyzers market, by test, 2018 - 2030 (USD Million)
  • Table 67 Brazil clinical chemistry analyzers market, by end use, 2018 - 2030 (USD Million)
  • Table 68 Mexico clinical chemistry analyzers market, by product, 2018 - 2030 (USD Million)
  • Table 69 Mexico clinical chemistry analyzers market, by test, 2018 - 2030 (USD Million)
  • Table 70 Mexico clinical chemistry analyzers market, by end use, 2018 - 2030 (USD Million)
  • Table 71 Argentina clinical chemistry analyzers market, by product, 2018 - 2030 (USD Million)
  • Table 72 Argentina clinical chemistry analyzers market, by test, 2018 - 2030 (USD Million)
  • Table 73 Argentina clinical chemistry analyzers market, by end use, 2018 - 2030 (USD Million)
  • Table 74 Colombia clinical chemistry analyzers market, by product, 2018 - 2030 (USD Million)
  • Table 75 Colombia clinical chemistry analyzers market, by test, 2018 - 2030 (USD Million)
  • Table 76 Colombia clinical chemistry analyzers market, by end use, 2018 - 2030 (USD Million)
  • Table 77 Peru clinical chemistry analyzers market, by product, 2018 - 2030 (USD Million)
  • Table 78 Peru clinical chemistry analyzers market, by test, 2018 - 2030 (USD Million)
  • Table 79 Peru clinical chemistry analyzers market, by end use, 2018 - 2030 (USD Million)
  • Table 80 MEA clinical chemistry analyzers market, by region, 2018 - 2030 (USD Million)
  • Table 81 MEA clinical chemistry analyzers market, by product, 2018 - 2030 (USD Million)
  • Table 82 MEA clinical chemistry analyzers market, by test, 2018 - 2030 (USD Million)
  • Table 83 MEA clinical chemistry analyzers market, by end use, 2018 - 2030 (USD Million)
  • Table 84 South Africa clinical chemistry analyzers market, by product, 2018 - 2030 (USD Million)
  • Table 85 South Africa clinical chemistry analyzers market, by test, 2018 - 2030 (USD Million)
  • Table 86 South Africa clinical chemistry analyzers market, by end use, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia clinical chemistry analyzers market, by product, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia clinical chemistry analyzers market, by test, 2018 - 2030 (USD Million)
  • Table 89 Saudi Arabia clinical chemistry analyzers market, by end use, 2018 - 2030 (USD Million)
  • Table 90 UAE clinical chemistry analyzers market, by product, 2018 - 2030 (USD Million)
  • Table 91 UAE clinical chemistry analyzers market, by test, 2018 - 2030 (USD Million)
  • Table 92 UAE clinical chemistry analyzers market, by end use, 2018 - 2030 (USD Million)
  • Table 93 Kuwait clinical chemistry analyzers market, by product, 2018 - 2030 (USD Million)
  • Table 94 Kuwait clinical chemistry analyzers market, by test, 2018 - 2030 (USD Million)
  • Table 95 Kuwait clinical chemistry analyzers market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Clinical Chemistry Analyzers Market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value chain-based sizing & forecasting
  • Fig. 7 QFD modelling for market share assessment
  • Fig. 8 Clinical Chemistry Analyzers Market snapshot (2023)
  • Fig. 9 Clinical Chemistry Analyzers Market: Segment snapshot (2023)
  • Fig. 10 Competitive Insights (2023)
  • Fig. 11 Parent market outlook
  • Fig. 12 Related/ancillary market outlook
  • Fig. 13 Penetration and growth prospect mapping
  • Fig. 14 Clinical Chemistry Analyzers Market driver impact
  • Fig. 15 Clinical Chemistry Analyzers Market restraint impact
  • Fig. 16 Clinical chemistry industry challenges
  • Fig. 17 Porter's Five Forces Analysis
  • Fig. 18 SWOT Analysis, By Factor (Political & legal Economic and technological)
  • Fig. 19 Strategic alliance analysis
  • Fig. 20 Recent developments & impact analysis, by key market participants
  • Fig. 21 Key company market share analysis, 2023
  • Fig. 22 Company market position analysis
  • Fig. 23 Definition and scope, by product
  • Fig. 24 Product market share analysis, 2023 & 2030
  • Fig. 25 Segment dashboard
  • Fig. 26 Global Clinical Chemistry Analyzers Market, by product, 2018 - 2030 (USD Million)
  • Fig. 27 Analyzers market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 28 Small market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 29 Medium market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 30 Large market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 31 Very large market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 32 Reagents market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 33 Calibrators market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 34 Controls market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 35 Standards market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 36 Others market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 37 Others market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 38 Definition and scope, by test
  • Fig. 39 Test market share analysis, 2023 & 2030
  • Fig. 40 Segment dashboard
  • Fig. 41 Global Clinical Chemistry Analyzers Market, by test, 2018 - 2030 (USD Million)
  • Fig. 42 Basic metabolic panel (BMP) market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 43 Electrolyte panel market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 44 Liver panel market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 45 Lipid profile market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 46 Renal profile market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 47 Thyroid function panel market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 48 Specialty chemical tests market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 49 Definition and scope, by end-use
  • Fig. 50 End-use market share analysis, 2023 & 2030
  • Fig. 51 Segment dashboard
  • Fig. 52 Global Clinical Chemistry Analyzers Market, by end-use, 2018 - 2030 (USD Million)
  • Fig. 53 Hospitals market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 54 Academic research centers market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 55 Diagnostic laboratories and market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 56 Others market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 57 Clinical Chemistry Analyzers Market: Snapshot, 2023
  • Fig. 58 North America Clinical Chemistry Analyzers Market share and leading players, 2023
  • Fig. 59 Europe Clinical Chemistry Analyzers Market share and leading players, 2023
  • Fig. 60 Asia Pacific Clinical Chemistry Analyzers Market share and leading players, 2023
  • Fig. 61 Latin America Clinical Chemistry Analyzers Market share and leading players, 2023
  • Fig. 62 Middle East and Africa Clinical Chemistry Analyzers Market share and leading players, 2023
  • Fig. 63 North America market share analysis by country, 2023
  • Fig. 64 Europe market share analysis by country, 2023
  • Fig. 65 Asia Pacific market share analysis by country, 2023
  • Fig. 66 Latin America market share analysis by country, 2023
  • Fig. 67 Middle East and Africa market share analysis by country, 2023
  • Fig. 68 North America market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 69 U.S. market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 70 Canada market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 71 Europe market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 72 UK market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 73 Germany market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 74 Spain market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 75 France market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 76 Italy market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 77 Denmark market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 78 Sweden market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 79 Norway market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 80 Asia Pacific market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 81 China market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 82 Japan market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 83 India market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 84 Australia market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 85 Thailand market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 86 South Korea market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 87 Latin America market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 88 Brazil market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 89 Mexico market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 90 Argentina market size, & forecasts and trend analysis, 2018 to 2030 (USD Million))
  • Fig. 91 Middle East and Africa market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 92 South Africa market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 93 Saudi Arabia market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 94 UAE market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 95 Kuwait market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)